Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4354100

CCC(O)(O)CN.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185900 0.97
SCHEMBL13732906 0.83 TSHR (0.32)
Sulfuric Acid SCHEMBL5424299 0.83 TP53 (0.32)
Tromethamine SCHEMBL9154957 0.81 MEN1 (0.50)
Acrylic Acid SCHEMBL18207682 0.75 LMNA (0.43)
Methylamine SCHEMBL28551477 0.74
SCHEMBL2012298 0.73
Hydrochloric Acid SCHEMBL1469929 0.73
SCHEMBL185336 0.71
Hydrochloric Acid SCHEMBL4698907 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8449880-B2 Chemical modification of proteins for their more accurate molecular-weight determination by electrophoresis DOLNIK VLADISLAV (US) 2013-05-28 US claimed
US-20120125775-A1 CHEMICAL MODIFICATION OF PROTEINS FOR THEIR MORE ACCURATE MOLECULAR-WEIGHT DETERMINATION BY ELECTROPHORESIS DOLNIK VLADISLAV (US) 2012-05-24 US claimed
EP-0369437-A2 Motilin preparation KYOWA HAKKO KOGYO CO., LTD. (JP) 1990-05-23 EP claimed
US-8449880-B2 Chemical modification of proteins for their more accurate molecular-weight determination by electrophoresis DOLNIK VLADISLAV (US) 2013-05-28 US disclosed
US-8431415-B2 Immunoassay using insoluble carrier particles and reagent therefor TFB, INC. (JP) 2013-04-30 US disclosed
US-20120125775-A1 CHEMICAL MODIFICATION OF PROTEINS FOR THEIR MORE ACCURATE MOLECULAR-WEIGHT DETERMINATION BY ELECTROPHORESIS DOLNIK VLADISLAV (US) 2012-05-24 US disclosed
US-20090286330-A1 Immunoassay using insoluble carrier particles and reagent therefor KYOWA MEDEX CO., LTD (JP) 2009-11-19 US disclosed
EP-1508616-B1 Method for stabilizing an aspartate aminotransferase and the corresponding compositions SYSMEX CORP (JP) 2006-10-25 EP disclosed
EP-1508617-B1 Method for stabilizing an alanine aminotransferase and the corresponding compositions SYSMEX CORP (JP) 2006-10-04 EP disclosed
EP-1508616-A1 Method for stabilizing and aspartate aminotransferase and the corresponding compositions International Reagents Corporation (JP) 2005-02-23 EP disclosed
EP-1508617-A1 Method for stabilizing an alanine aminotransferase and the corresponding compositions International Reagents Corporation (JP) 2005-02-23 EP disclosed
EP-1136550-B1 METHOD FOR STABILIZING ASPARTATE AMINOTRANSFERASE AND THE CORRESPONDING COMPOSITIONS INT REAGENTS CORP (JP) 2004-12-15 EP disclosed
US-20040053426-A1 Method of immunity examination with insoluble carrier particle and reagent therefor KYOWA MEDEX CO., LTD. (JP) 2004-03-18 US disclosed
EP-1136550-A1 METHOD FOR STABILIZING ENZYMES AND ENZYME COMPOSITIONS INTERNATIONAL REAGENTS CORPORATION (JP) 2001-09-26 EP disclosed
US-6251618-B1 REACTION OF INDOYL DERIVATIVE WITH ENZYME IN PRESENCE OF SPECIFIC FREE RADICAL COMPOUND AND/OR CHELATE COMPOUND REDUCES TIME REQUIRED FOR DEVELOPMENT FUJIREBIO INC. (JP) 2001-06-26 US disclosed
US-5998156-A MEASURING ENZYME ACTIVITY USING ENZYME LABELED ANTIBODY OR ANTIGEN FUJIREBIO INC. (JP) 1999-12-07 US disclosed